Skip to content

Broadly neutralising antibodies plus immune modulator may delay HIV rebound

US funding cuts cause immediate drops in numbers testing and on HIV treatment

International HIV funding crisis threatens millions of lives, researchers warn

Conflicts and humanitarian crises create new HIV vulnerabilities

The US cuts challenge African funders and governments to provide new models of PrEP access

Children born with HIV have persistent inflammation markers linked to heart disease

Stepping into the AI-driven future of HIV prevention and care

Does six-monthly PrEP have a future following the collapse of global HIV funding?

Is HIV integration a response or a death sentence? Communities demand answers

The funding scramble: countries desperately seek HIV finance solutions

Lenacapavir PrEP ‘special cases’: young people, missed doses and drug interactions

Integration of HIV services – what does that really mean?

U=U applies for some pregnancies, but breastfeeding questions remain

If mother has undetectable viral load from conception to birth, HIV is untransmittable

Trans and gender diverse people face multiple barriers accessing UK sexual health services

Despite U=U, concerns about sharing HIV status persist among older people

Low-level but detectable HIV raises the risk of treatment failure, but not long-term harm

Turning HIV’s power against itself may help target hidden virus – another step towards a cure

People with HIV report little difference in quality of life compared with matched controls, but more depression

More Europeans are dying from HIV now than 15 years ago